Zimmer Biomet Holdings, Inc.’s Stock Price Soars to $112.54, Marking a Robust 3.39% Uptick: A Noteworthy Surge in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (ZBH)

112.54 USD +3.69 (+3.39%) Volume: 2.58M

Zimmer Biomet Holdings, Inc.’s stock price is currently valued at 112.54 USD, showcasing an impressive rise of +3.39% in this trading session with a substantial trading volume of 2.58M. However, the company’s year-to-date (YTD) performance reflects a decrease of -7.53%, indicating a dynamic market presence.

Latest developments on Zimmer Biomet Holdings, Inc.

Following a series of significant events, Zimmer Biomet Holdings Inc. experienced fluctuations in its stock price today. The company recently welcomed Arnold Schwarzenegger as the Chief Movement Officer in a landmark partnership, which generated buzz in the market. Additionally, Sivik Global Healthcare LLC made a substantial investment in Zimmer Biomet, while Principal Financial Group Inc. sold a significant number of shares. Despite underperforming compared to competitors on some days, Zimmer Biomet Holdings saw a strong trading day where its stock outperformed others in the industry. These developments have contributed to the stock price movements of Zimmer Biomet Holdings today.

A look at Zimmer Biomet Holdings, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Zimmer Biomet Holdings has a positive long-term outlook. With high scores in Value and Momentum, the company is positioned well for growth and potential returns for investors. Additionally, its solid score in Dividend indicates a stable payout for shareholders. However, Zimmer Biomet Holdings scored lower in Resilience, suggesting potential vulnerability to market fluctuations.

Zimmer Biomet Holdings, Inc. is a global company that specializes in medical equipment, particularly in orthopedic, dental, and spinal reconstructive implants. With a focus on innovation and serving patients worldwide, the company’s strong Value and Momentum scores point towards a promising future in the medical equipment industry. Although it scored lower in Resilience, Zimmer Biomet Holdings’ overall outlook remains optimistic with solid scores in Growth and Dividend.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma